title: Prenatal screening of sialic acid storage disease and confirmation in cultured fibroblasts by LC-MS/MS.
abstract: Sialic acid storage disease (SASD) is an inborn error resulting from defects in the lysosomal membrane protein sialin. The SASD phenotypical spectrum ranges from a severe presentation, infantile sialic acid storage disease (ISSD) which may present as hydrops fetalis, to a relatively mild form, Salla disease. Screening for SASD is performed by determination of free sialic acid (FSA) in urine or amniotic fluid supernatant (AFS). Subsequent diagnosis of SASD is performed by quantification of FSA in cultured fibroblasts and by mutation analysis of the sialin gene, SLC17A5. We describe simple quantitative procedures to determine FSA as well as conjugated sialic acid in AFS, and FSA in cultured fibroblasts, using isotope dilution ((13)C(3)-sialic acid) and multiple reaction monitoring LC-ESI-MS/MS. The whole procedure can be performed in 2-4 h. Reference values in AFS were 0-8.2 μmol/L for 15-25 weeks of gestation and 3.2-12.0 μmol/L for 26-38 weeks of gestation. In AFS samples from five fetuses affected with ISSD FSA was 23.9-58.9 μmol/L demonstrating that this method is able to discriminate ISSD pregnancies from normal ones. The method was also validated for determination of FSA in fibroblast homogenates. FSA in SASD fibroblasts (ISSD; 20-154 nmol/mg protein, intermediate SASD; 12.9-15.1 nmol/mg, Salla disease; 5.9-7.4 nmol/mg) was clearly elevated compared to normal controls (0.3-2.2 nmol/mg). In conclusion, we report simple quantitative procedures to determine FSA in AFS and cultured fibroblasts improving both prenatal diagnostic efficacy for ISSD as well as confirmatory testing in cultured fibroblasts following initial screening in urine or AFS.
authors: Department Clinical Genetics, Erasmus Medical Center, Dr. Molewaterplein 50, 3015GE, Rotterdam, The Netherlands.
authors: Jeroen
authors: J
authors: van den Bosch
authors: Linda F
authors: LF
authors: Oemardien
authors: Malgorzata I
authors: MI
authors: Srebniak
authors: Monique
authors: M
authors: Piraud
authors: Jan G M
authors: JG
authors: Huijmans
authors: Frans W
authors: FW
authors: Verheijen
authors: George J G
authors: GJ
authors: Ruijter
references: Clin Chim Acta. 2006 Sep;371(1-2):176-82
references: 16674934
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2010 May 1;878(15-16):1098-102
references: 20362517
references: Eur J Pediatr. 1992 Aug;151(8):590-5
references: 1505579
references: Mol Genet Metab. 2005 Jun;85(2):85-7
references: 15973781
references: J Biol Chem. 1991 Apr 25;266(12):7456-61
references: 2019577
references: Prenat Diagn. 2006 Aug;26(8):655-8
references: 16715535
references: Clin Chim Acta. 1996 Apr 30;248(2):143-55
references: 8740579
references: Am J Med Genet. 1987 Oct;28(2):377-84
references: 3425617
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):251-7
references: 17123874
references: Nat Genet. 1999 Dec;23(4):462-5
references: 10581036
references: Am J Hum Genet. 2000 Oct;67(4):832-40
references: 10947946
references: Science. 1986 May 9;232(4751):759-62
references: 3961501
references: J Med Genet. 2005 Nov;42(11):829-36
references: 15805149
references: Genet Couns. 1999;10(3):277-84
references: 10546100
references: Adv Pediatr. 1999;46:409-40
references: 10645471
references: Clin Lab. 2006;52(3-4):155-69
references: 16584062
references: Pediatr Neurol. 2002 Apr;26(4):267-73
references: 11992753